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Abstract
Aims We undertook a mixed-methods evaluation of a Web-based conferencing service (virtual consult) between general
practitioners (GPs) and cardiologists in managing patients with heart failure in the community to determine its effect on
use of specialist heart failure services and acceptability to GPs.
Methods and results All cases from June 2015 to October 2016 were recorded using a standardized recording template,
which recorded patient demographics, medical history, medications, and outcome of the virtual consult for each case.
Quantitative surveys and qualitative interviewing of 17 participating GPs were also undertaken. During this time, 142 cases
were discussed—68 relating to a new diagnosis of heart failure, 53 relating to emerging deterioration in a known heart failure
patient, and 21 relating to therapeutic issues. Only 17% required review in outpatient department following the virtual
consultation. GPs reported increased conﬁdence in heart failure management, a broadening of their knowledge base, and a
perception of overall better patient outcomes.
Conclusions These data from an initial experience with Heart Failure Virtual Consultation present a very positive impact of
this strategy on the provision of heart failure care in the community and acceptability to users. Further research on the
implementation and expansion of this strategy is warranted.
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Introduction
Many challenges remain in the management of heart failure
(HF) with suboptimal implementation of guideline-
recommended therapies, a changing proﬁle of patients who
are older and have multiple co-morbidities, and a high rate
of early re-hospitalization for HF.1 Overall, the management
of HF remains fragmented, and concerted action by all
professionals concerned is needed. In particular, there is a lack
of cohesive interaction between primary care, where HF care
should be centred and co-morbidities managed, and specialist
cardiologist input for advice and involvement on aspects of
management at critical phases of the life cycle of an HF patient.
In the early 2000’s, publications suggested that only a third of
those with a clinical diagnosis of HF had echocardiography or
further referral,2 and this has not changed signiﬁcantly in a
more recent study.3 A publication this year from the
Netherlands4 showed that 31% of the conﬁrmed HF patient
cohort of 434 people were managed solely within the primary
care structure as deﬁned by no cardiology contact with the
patient within an 18-month period.
This lack of effective interaction leads to inaccurate
delayed diagnosis, suboptimal management including self-
care, increasing likelihood of poor outcomes.
Use of modern communications systems has the potential
to revolutionize primary care–secondary care interactions.
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Online, real-time consultations between the general
practitioner (GP) and the specialist can provide speedy,
focused interaction on speciﬁc issues of care, often
circumventing the need for patient travel. In addition, the
capacity to allow multiple users observe and participate in
each consultation enables knowledge dissemination. Similar
initiatives in other disease areas have had impressive results
on disease management.5 This study focusing on hepatitis C
management showed that patients with hepatitis C infection
can be managed as effectively in primary care using an online
Web conferencing model between GPs and hepatologists as
patients attending an academic medical centre in terms of
sustained virological response to therapy.
We have recently deployed a GP specialist online, real-
time interaction to discuss patient’s problems in HF. This
application, which we refer to as ‘Virtual Consultation’, can
host at one sitting up to 25 GP practices, enabling speciﬁc
case discussion and also a dissemination of practical tips in
HF care. This strategy offers an alternative to standard clinic
assessment, can provide the GP with all the information that
he or she requires, can reduce need for onward direct
referral and thereby can reduce ‘unnecessary’ travel for the
patient and family, a very meaningful bonus for this type of
interaction given the age and frailty of many patients with
HF. This intervention also provides a user-friendly method
to update the care strategy for a patient without necessarily
requiring the patient to travel.
The patient-speciﬁc aspect of the service is complimented
with a brief continuing medical education (CME) session at the
beginning of each clinic on practical issues related to HF care.
This study was a prospective observational study of the
cases referred to this service between June 2015 and October
2016 along with a qualitative and quantitative study of GP
perceptions of the service and possibilities for further
development.
Methods
The Heart Failure Virtual Consultation service
The Heart Failure Virtual Consultation (HFVC) was established
in the St Vincent’s Heart Failure Unit in January 2015.
The HFVC runs fortnightly, and GPs receive an invitation
approximately 10 days prior to each session. The invitation
provides information on the date of the session, the
education topic to be covered that week and a request to
send in a case where diagnostic or therapeutic advice is
needed. A GP may send in a case or may simply sign in to
hear/contribute to other GP cases being discussed. For those
who wish to have a case discussed, the GP completes a
referral form and returns it to the HFVC team by fax or secure
e-mail with patient details anonymized. The HFVC team then
prepares the case, outlining the patient’s clinical history and
the clinical question(s) for presentation on slides during the
HFVC.
The HFVC session begins with the HF specialist providing a
10 min didactic education session during which GPs can ask
questions. Following the education session, cases are
discussed sequentially. The GP to whom the case applies
discusses the case at the outset, and slides outlining
anonymized patient data are viewable by all participants.
Other GPs may also contribute to the discussion, creating a
dynamic learning environment. At the end of each case, a
management plan is agreed on, and a letter outlining this
was returned to the referring GP.
Analysis
Clinical review
All cases from June 2015 to October 2016 were recorded
using a standardized recording template, which recorded
patient demographics, medical history, medications, and
outcome of the HFVC for each case. Cases were categorized
as relating to potential new diagnosis of HF, therapeutic
questions in an established case of HF or issues related to
emerging HF deterioration.
General practitioner user satisfaction with the Heart Failure
Virtual Consultation clinic
This was assessed using a mixed-methods approach,
combining quantitative surveys and qualitative interviewing.
A total of 30 GP practices utilized the service during the
study. A number of GPs may be involved in single GP practice,
and it is not possible to determine how many individual GPs
in each practice have been involved. Seventeen GPs who had
participated in the HFVC, all from different practices,
responded to invitations to participate in this study. Survey
data were collected using Likert-scale statements that
participants rated from 1 (strongly disagree) to 5 (strongly
agree), and participants were then asked to participate in
qualitative interviews also. The qualitative interviews
explored the topics covered in the survey in more depth
and provided the participant with an opportunity to add
any additional information and make recommendations
arising out of their experiences. The average duration of the
interviews was 35 min. Interviews were conducted through
face-to-face meetings and over the telephone.
Metrics of patient convenience
Two metrics of patient convenience were noted: (i) need for
subsequent use of standard outpatient service and or
emergency department (ED) for an HF-related issue despite
the use of the HFVC and (ii) kilometres of travel saved as a
result of not requiring standard clinic review based on
distance from the GP practice to St Vincent’s Heart Failure
Unit. This was calculated for all patients not requiring a
traditional outpatient review in the clinic, as it was assumed
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that otherwise these patients would have travelled to the
clinic for an outpatient appointment for specialist review.
Statistical analysis
Descriptive statistics were applied to the data using
GraphPad Prism 6 (GraphPad Software, Inc., La Jolla, CA,
USA).
Results
Nature of case, agreed intervention and outcome
Between June 2015 and October 2016, 142 cases were
discussed at the HFVC. The demographics of the patients are
presented in Table 1. New diagnostic cases and emerging
deterioration cases are equally distributed between male and
female cases, with the therapeutic cases being predominantly
female. Themedian ages are similar between the groups ranged
from 74 to 79.5 years. A high incidence of ischaemic heart
disease in emerging deterioration cases is noted. This likely
reﬂects the burden of decompensation risk in both HF types
(i.e. reduced ejection fraction and preserved ejection fraction)
in those with a prior diagnosis of ischaemic heart disease.
The nature of the cases discussed and outcomes is
highlighted in Table 1 and Figure 1 along with the agreed
intervention. The diagnostic cases required more
interventions after the HFVC compared with the emerging
deterioration and therapeutics cases. In the new diagnostic
category, the interventions mostly related to the need for a
repeat HFVC to discuss results of investigation such as
echocardiography and form a therapeutic plan, therapeutic
changes, NP testing, and referral for echocardiography to
conﬁrm HF sub-types. In the emerging deterioration category,
therapeutic changes were most common, followed by
natriuretic peptide (NP) testing and, if need be, repeat HFVC.
The outcome for the new diagnostic case is described in
Table 2. The ratio of HF, not HF, and indeterminate HF
diagnosed on ﬁrst consultation is almost equal to that after
the HFVC. The indeterminate HF cases were arranged for
follow-up tests and review with the HFVC.
Overall, 17% of cases required review in person by an HF
specialist following the HFVC.
Usability
A total of 30 GP practices utilized the service during the
study. Seventeen GPs who had participated in the HFVC, all
from different practices, responded to invitations to
participate in this study.
Of the 17 GPs who have signed into the HFVC, nine used
the service one to ﬁve times; six, six to 12 times; and two,
13–20 times.
Table 1 Demographics
New diagnostic case
n = 68
Emerging deterioration case
n = 53
Therapeutic case
n = 21
Gender (n, %)
Male 33 (48.5) 23 (43.4) 5 (23.8)
Female 35 (51.5) 30 (56.6) 16 (76.2)
Age, years (med [IQR]) 78.5 [70.8:94] 79.5 [73:83] 74 [69.5:79]
Risk factors and co-morbidity (n, %)
Hypertension 33 (48.5) 22 (41.5) 14 (66.7)
Atrial ﬁbrillation 24 (35.3) 20 (37.7) 7 (33.3)
Ischaemic heart disease 11 (16.2) 23 (43.4) 11 (52.4)
Valve disorder 4 (5.9) 1 (1.9) 1 (4.8)
Diabetes mellitus 18 (26.5) 9 (16.9) 20 (95.2)
Lipid disorder 10 (14.7) 9 (16.9) 8 (38.1)
Chronic obstructive pulmonary disease 7 (10.2) 10 (18.9) 2 (9.5)
Renal impairment 10 (14.7) 15 (28.3) 4 (19.0)
Anaemia 0 (0) 9 (16.9) 1 (4.8)
Depression 4 (5.9) 6 (11.3) 1 (4.8)
Medication (n, %)
ACE-I/ARB 38 (55.9) 29 (54.7) 14 (66.7)
Beta-blocker 33 (48.5) 33 (67.9) 17 (81.0)
MRA/AA 0 (0) 5 (9.4) 1 (4.8)
Diuretic 42 (61.8) 39 (73.6) 10 (47.6)
Oral anticoagulant 14 (20.6) 15 (28.3) 6 (28.6)
Ivabradine 1 (1.5) 0 (0) 0 (0)
Digoxin 7 (10.3) 8 (15.1) 4 (19)
Statin 33 (48.5) 29 (54.7) 18 (85.7)
Nitrate 1 (1.5) 6 (11.3) 2 (9.5)
AA, Aldosterone antagonist; ACE-I, ACE inhibitor; ARB, Angiotensin Receptor Blocker; IQR, Interquartile range; MRA, Mineralocorticoid
Receptor Antagonist.
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The majority of participants rated the technology
statements positively with a mean rating of 4.00 to 4.47
(Table 3). However, a limited number of participants reported
issues related to insufﬁcient information being provided prior
to participating, difﬁculty in terms of signing in and
dissatisfaction with the technology generally. This cohort
discussed a need for information technology support to
address technical issues when they arose.
On the second occasion I couldn’t get a connection
and there didn’t seem to be anybody to talk me
through it or get me out of the predicament I was
in …. I could hear what was going on but I couldn’t
see anything … I couldn’t see the details of the case
so I didn’t know what they were talking about …
even somebody that I could have telephoned at the
start of the meeting … usually it’s something I have
done. (GPU003)
Furthermore, during the interview phase of the study, a
number of participants discussed a need for a comprehensive
video guide on how to download the software, how to use
the software, best positioning for the technology, and how
to participate (procedure).
Another technology concern raised during the interviewing
phase of the study was data protection and a perceived lack
of information surrounding security issues. For example,
one participant discussed being unsure of whether there
was an encryption of the information and whether their
discussion was being recorded and had the potential to be
Figure 1 Outcome of Heart Failure Virtual Consultation (HFVC). DCCV, direct current cardioversion.
Table 2 Outcome of new diagnostic case
n = 68 Conﬁrm HF Not HF Indeterminate HF
Outcome (n, %) 24 (35.3) 25 (36.8) 19 (27.9)
HF, heart failure.
Table 3 General practitioner experience of using the virtual clinic (n = 17)
Strongly
agree (%) Agree (%)
Neither agree
nor disagree (%) Disagree (%)
Strongly
disagree (%) Mean (SD)
I feel I was provided with sufﬁcient
information prior to participation
in the clinic
59 29 6 6 0 4.41 (0.71)
I found signing into the clinic easy 35 41 12 12 0 4.00 (1.0)
I found participating in the clinic easy 53
I have been satisﬁed with the
technology such as the software
41 35 12 6 6 4.00 (1.2)
The technology for the clinic functions
smoothly
35 29 17 6 6 4.18 (0.73)
The referral form allows me to record
all the information I need to
adequately discuss my case
30 47 24 0 0 4.06 (0.75)
I am satisﬁed that I receive adequate
support when I present a case to the
clinic
36 47 18 0 0 4.18 (0.73)
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taken out of context at a later point in time. These issues are
easily remedied through the provision of more in-depth
information packs when a GP is being invited to participate
and the setting up of an information technology support
system.
In terms of usability, the majority of GPs felt conﬁdent
enough to engage with such technology and discussed the
model in terms of ease of set-up engagement. As such,
ﬁndings do not suggest that technology is a barrier to
participation.
Self-reported efﬁcacy
This study also explored whether GPs felt they experienced
any beneﬁts to their professional development through
participation with the HFVC. The majority of participants
either strongly agreed or agreed with statements related to
increased conﬁdence, broadening of their knowledge base,
and better patient outcomes, with mean ratings ranging from
4.35 to 4.47 (Table 4).
During the interview phase of the study, GPs reported
engagement with the HFVC as having positive impacts upon
referring patients to secondary and tertiary care, whereby
all participants reported reducing referrals as a result of
having increased knowledge and conﬁdence to manage a
cohort of HF patients in the community.
I have learned more about the more appropriate
treatments and I have been able to use that on other
patients. My own personal knowledge of heart failure
has improved. … it’s [HFVC] got the ability to
improve the diagnosis and therefore improve
treatment at an earlier stage and they get managed
better and better care at primary care. Then their
referral on the secondary and tertiary care is delayed.
(GPU007)
It’s [HFVC] given me a conﬁdence level, I mean I can’t
remember the last time that I sent someone in. I
mean I kind of know, at this stage, most of the tricks.
(GPU011)
When asked during interview how patients reacted when
informed that their case was being discussed at the HFVC,
all participants agreed that patients were very pleased with
the model, were happy to have their condition discussed with
experts and a group of GPs and were relieved at not being
referred to the outpatient department:
Always [tell the patient that the case will be
discussed], they are very happy—I tell them that I
am going to talk to an expert in heart failure and
you won’t have to go along yourself. Usually they
are older patients and hate the idea of going to
Table 4 General practitioner reports of beneﬁts related to participation with the virtual clinic (n = 17)
Strongly
agree (%) Agree (%)
Neither agree
nor disagree (%) Disagree (%)
Strongly
disagree (%) Mean (SD)
Participation in the clinics has
improved my conﬁdence in
identifying HF
29 47 18 0 0 4.41 (1.37)
Participation in the clinic
improved my ability to care
for patients with HF
41 53 6 0 0 4.36 (0.61)
I feel I learn best practice in
HF through my participation
in HF virtual clinic
41 53 6 0 0 4.36 (0.61)
I am able to connect with my
peers and colleagues through
participation in the clinic
35 53 12 0 0 4.42 (0.66)
Discussions with other
participants of the clinic
enhanced my knowledge
of HF
41 53 6 0 0 4.36 (0.61)
Case-based learning increased
my knowledge about HF
41 59 0 0 0 4.41 (0.51)
The didactic presentation
enhanced my knowledge
about HF
41 53 6 0 0 4.24 (0.83)
I ﬁnd the advice I get from
the clinic is useful when
treating my patients in
surgery
47 53 0 0 0 4.47 (0.51)
I feel my patients have
beneﬁted as a result of my
participation in the clinic
47 53 0 0 0 4.47 (0.51)
HF, heart failure.
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outpatients and I can go present all their results and
information to the clinic and they are very pleased
with it. No-one has ever said to me that they are
unhappy with it or complained. (GPU010)
Participants were also asked whether, in their experience,
participation with the HFVC had reduced the number of HF
referrals made to the secondary/tertiary care system. The
majority of participants either strongly agreed or agreed that
the HFVC had facilitated keeping a cohort of patients, who
would likely otherwise have been referred, in the primary
care setting (Table 4).
Metrics of patient convenience
None of the patients with emerging deterioration required
referral to the ED or hospital admission. Thirty-six cases had
a repeat HFVC discussion. The total distance travel saved
from all cases to date has been 10 552 km.
Discussion
This study shows the beneﬁts of the HFVC from both health
system and health professional perspectives. The HFVC can
adequately and safely deal with the many of the queries that
otherwise would have required outpatient department
attendance. GPs also reported increased conﬁdence in HF
management, a broadening of their knowledge base, and a
perception of overall better patient outcomes. Finally, in
safely managing many issues by this method, the
inconvenience of travel for the patient and his or her family
has been avoided.
Heart failure has become an increasingly complex
condition with difﬁculties in diagnosis, often reﬂecting the
attendant co-morbidities, complex diagnostics required to
fully understand aetiology, and a wide variety of
pharmacological and non-pharmacological therapeutic
strategies.6 It has been shown that given the complexity of
HF, there is an understandable lack of conﬁdence in many
of the aspects of HF care among GPs.7 Therefore, it is
important to ensure that specialist opinion is readily available
particularly as it is proposed that more patients can be
discharged from specialist clinics to community settings.8,9
Present communication paths, predominantly ofﬂine, and
often by referral letter necessitating an outpatient review
do not allow easy communication between professionals
and can lead to disjointed care. For example, one study
demonstrated that HF patients reported too many
medications and appointments, barriers to accessing services,
fragmented and poorly organized care, lack of continuity, and
inadequate communication between health professionals as
components to treatment burden that they experienced.10
Optimal and timely communication between GPs and
cardiologists can help ensure that appropriate care is
provided and reduce many of these elements of treatment
burden. A previous study indicated that virtual primary care
consultations with cardiologists can reduce ED visits. This
study used asynchronous electronic consultations and found
that this service could resolve about two-thirds of cardiac
concerns without a specialist visit and reduced cardiac
related ED visits during the 6 month follow-up period.11 The
use of a structured service such as the HFVC allows timely
communication and addresses certain limitations of phone
calls or unstructured emails such as incomplete data and lack
of documentation of the interaction. It also preserves the
advantages of such interactions such as a timely response,
case-based education, building of relationships between
GPs and specialists, identiﬁcation of cases that require formal
consultation, and the patient convenience and cost savings
associated with avoiding an in-person visit.
Accessible and relevant education for GPs and access to
specialist opinion is essential if they are to be enabled to
provide high quality care in a rapidly evolving healthcare
environment. This is particularly challenging within a
community context as GPs may work in isolated settings, with
varied access to educational opportunities and peer review of
practice. New or innovative approaches employing eHealth
strategies pose a potential solution to these issues, but most
studies of telemedicine are methodologically weak and often
focus on feasibility and acceptability to patients rather than
discrete clinical outcomes such as mortality or
hospitalizations.12 There may also be unintended
consequences. For example, even if a virtual consult is more
efﬁcient than a face-to-face encounter, if it leads to more
encounters overall, healthcare costs will increase. One study
found that follow-up visits increased particularly in specialties
that required specialized examination techniques such as ENT
and orthopaedics.13 However, HF is a condition that is
particularly suited to this model as modalities such as
echocardiography can now be provided in the community
and interpreted remotely.
While our initial experience has been positive, it is clear
that the use of HFVC requires reﬁnement. Ensuring that the
technology is both appropriate and secure is vital and brings
a new member to the multidisciplinary team in HF—the
information technology specialist. It is possible that providing
education initiatives in the manner outlined might increase
referral through GPs becoming aware of some aspects of care
previously not known, and this was not explicitly evaluated in
this study. The study had a relatively small sample size, so
broad conclusions cannot be drawn, and indeed, a
randomized controlled trial of this methodology is warranted
to determine its effect on clinical and patient reported
outcomes. Patients’ experience was not assessed and is also
an area for future exploration. Overall, however, the use of
this mixed-methods approach provides valuable data on the
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development and use of this service, its potential, and areas
requiring further exploration.
Conclusions
These data from an initial experience with HFVC present the
positive impact of this strategy on the provision of HF care in
the community and acceptability to users. In addition, it is
likely that this strategy will have beneﬁts in the management
of other chronic illnesses, and therefore, increased focus on
and resourcing of such efforts may have a signiﬁcant impact
on the development of chronic disease strategies in the
future. Further research on this strategy focusing on patient
outcomes and acceptability, implementation science
approaches, and economic evaluations is required.
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